John Robertson

Cooley advised zulily on its $2.4 billion sale to Liberty Interactive, parent company of QVC.

Zulily is an e-commerce flash-sales site. Liberty Interactive owns interests in subsidiaries and other companies that are primarily engaged in the video and digital commerce industries.

Zulily has been a Cooley client since its formation in 2009. The founders of zulily, Mark Vadon and Darrell Cavens, came from Cooley client BlueNile, which Mark Vadon also founded. In 2013, Cooley took zulily public.

The team advising zulily on its sale to Liberty included John Robertson, Alan Hambelton, Julia Conway, Colleen Burns, Brian Woodard, Frederick Baron, Lois Voelz, Barbara Mirza, Mark Tanoury, Jamie Leigh, Kevin King, Danish Hamid, Karen Tsai and Mike Tollini.

Seattle – Cooley advised zulily on its $253 million initial public offering. Zulily is a flash sales website that targets moms and their children. The company now trades on the Nasdaq Global Market under the symbol "ZU."

Cooley advised Accolade on its $253.6 million initial public offering of 11,526,134 shares of common stock, including full exercise of the underwriters’ option to purchase additional shares. Accolade, whose securities now trade on the Nasdaq Global Select Market under the symbol “ACCD,” is a healthcare technology company that provides personalized healthcare services and benefits solutions to employees using a range of technologies. Partners John Robertson and Alan Hambelton led the Cooley team.

Cooley advised Molecular Partners on its $63.75 million initial public offering of 7,000,000 American depositary shares. Molecular Partners, whose securities now trade on the Nasdaq Global Select Market  under the symbol MOLN, is a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics. Partners Div Gupta, Ryan Sansom, Brandon Fenn and John Robertson led the Cooley team.

Cooley advised Accolade on its offering of $287.5 million principal amount of 0.50% convertible senior notes due 2026. Accolade, whose securities trade on the Nasdaq Global Select Market  under the symbol ACCD, is a provider of personalized, technology-enabled solutions that help people to understand, navigate and utilize the healthcare system and their workplace benefits.Partners Mischi a Marca, Alan Hambelton, John Robertson, and Jason Savich led the Cooley team.